Particularly, IL-1β, the β subunit of IL-1, has been demonstrated to significantly alter the TME and subverting anti-tumor immunity beyond directly promoting tumor cell proliferation [20, 22, 23]. The gene discussed is IL1B; the disease is neoplasm.